NovaBay Pharma (NBY) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
General and administrative: 2.22M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
General and administrative: 2.22M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $90 thousand versus the consensus estimate of $200 thousand.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
- Cantor Fitzgerald Reiterates Overweight Rating on Global Net Lease (GNL)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
